List of insiders holdings for GW PHARMACEUTICALS PLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Gangolli Julian S President, North America | 2019-05-14 21:00:24 | 117,151 0 | 117,151 | Form 4 |
| Lynch Thomas G Director | 2019-03-05 21:04:08 | 25,980 0 | 25,980 | Form 4 |
| George Adam D. Secretary | 2021-01-25 19:37:07 | 24,700 0 | 24,700 | Form 4 |
| Waldegrave William A. Director | 2021-05-07 16:15:16 | 0 0 | 0 | Form 4 |
| Brown Cabot Director | 2021-05-07 16:15:23 | 0 0 | 0 | Form 4 |
| Gover Justin D. Chief Executive Officer | 2021-05-07 16:15:42 | 0 0 | 0 | Form 4 |
| GUY GEOFFREY W DR Executive Chairman | 2021-05-07 16:15:35 | 0 0 | 0 | Form 4 |
| Giacobello Scott M. Chief Financial Officer | 2021-05-07 16:15:31 | 0 0 | 0 | Form 4 |
| MACKEY CATHERINE J Director | 2021-05-07 16:15:37 | 0 0 | 0 | Form 4 |
| Knappertz Volker Chief Medical Officer | 2021-05-07 16:15:36 | 0 0 | 0 | Form 4 |
| Secor Alicia Director | 2021-05-07 16:15:31 | 0 0 | 0 | Form 4 |
| Noble James Director | 2021-05-07 16:15:39 | 0 0 | 0 | Form 4 |
| Snyder Douglas B. Chief Legal Officer | 2021-05-07 16:15:52 | 0 0 | 0 | Form 4 |
| GRYSKA DAVID W Director | 2021-05-07 16:19:12 | 0 0 | 0 | Form 4 |
| Cline Darren S U.S. Chief Commercial Officer | 2021-05-07 16:21:57 | 0 0 | 0 | Form 4 |
| Tovey Christopher J. Chief Operating Officer | 2021-05-07 16:25:12 | 0 0 | 0 | Form 4 |